C-1 Esterase Inhibitor (iBio)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameC-1 Esterase Inhibitor (iBio)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinNatural product/Extract

Mechanisms of ActionComplement C1s inhibitors

TargetsComplement C1s

Therapy Area/IndicationsInflammationAngioedemas, Hereditary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIbio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIbio Inc

Active IndicationsN/A

Inactive IndicationsInflammationAngioedemas, Hereditary

ATC CodeN/A